XT
RLAY icon

XTX Topco’s Relay Therapeutics RLAY Stock Holding History

XTX Topco’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
75,782
-113,158
-60% -$1.64M 0.02% 1459
2026
Q1 		$1.88M Buy
188,940
+31,534
+20% +$282K 0.03% 884
2025
Q4 		$1.33M Buy
+157,406
New +$1.12M 0.04% 827
2025
Q3 		– Sell
-241,230
Closed -$835K – 3156
2025
Q2 		$835K Buy
241,230
+161,317
+202% +$480K 0.03% 781
2025
Q1 		$209K Buy
79,913
+20,161
+34% +$79K 0.01% 1667
2024
Q4 		$246K Buy
59,752
+12,481
+26% +$67.9K 0.02% 1382
2024
Q3 		$335K Buy
47,271
+10,311
+28% +$77K 0.02% 1115
2024
Q2 		$241K Buy
36,960
+629
+2% +$4.3K 0.02% 1102
2024
Q1 		$302K Buy
36,331
+25,262
+228% +$246K 0.04% 850
2023
Q4 		$122K Sell
11,069
-11,862
-52% -$100K 0.03% 1092
2023
Q3 		$193K Buy
22,931
+5,216
+29% +$56.1K 0.03% 1027
2023
Q2 		$223K Buy
+17,715
New +$220K 0.04% 940
2023
Q1 		– Sell
-12,795
Closed -$191K – 1606
2022
Q4 		$191K Buy
+12,795
New +$245K 0.04% 863
2022
Q1 		– Sell
-7,174
Closed -$220K – 907
2021
Q4 		$220K Buy
+7,174
New +$227K 0.12% 329

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

XTX Topco's RLAY Position: Q2 2026 in Review

XTX Topco reduced its Relay Therapeutics (RLAY) stake by 60% in Q2 2026, selling an estimated $1.64M and leaving 75,782 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #1459.

XTX Topco first reported a position in RLAY in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.88M in Q1 2026. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • XTX Topco held 75,782 shares of Relay Therapeutics worth $1.42M as of Q2 2026.
  • XTX Topco sold 113,158 Relay Therapeutics shares in Q2 2026, an estimated $1.64M.
  • Relay Therapeutics made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1459 holding.
  • XTX Topco first reported a position in Relay Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • XTX Topco's Relay Therapeutics position peaked at $1.88M in Q1 2026.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.